SCHEDULE 13G/A: ARK Investment Management and Catherine Wood Maintain 8.6% Stake in Absci Corp

ARK Investment Management LLC and Catherine D. Wood have jointly filed an amended Schedule 13G, reporting a combined beneficial ownership of 8.60% in Absci Corp's common stock as of March 31, 2025.

Summary

• ARK Investment Management LLC and Catherine D. Wood, acting as reporting persons, have filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership in Absci Corp.
• As of March 31, 2025, the reporting persons collectively beneficially own 10,955,089 shares of Absci Corp's Common Stock.
• This represents 8.60% of the class of Absci Corp's Common Stock.
• ARK Investment Management LLC holds sole voting and dispositive power over all 10,955,089 shares.
• Catherine D. Wood holds shared voting and dispositive power over all 10,955,089 shares.
• The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Absci Corp.
• ARK Genomic Revolution ETF, a series of a Delaware statutory trust, is identified as a client of ARK Investment Management LLC with an interest exceeding 5% in the reported securities.

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of beneficial ownership by a significant institutional investor. The continued substantial stake by ARK Investment Management and Catherine D. Wood could be interpreted as a positive signal of their ongoing confidence in Absci Corp, though the filing itself is purely informational and not indicative of new strategic developments.

Positives

• ARK Investment Management LLC and Catherine D. Wood, prominent investors, have maintained a significant stake of 8.60% in Absci Corp, indicating continued confidence in the company.

Future Outlook

NA

Industry Context

This filing indicates continued investment by ARK Investment Management, known for its focus on disruptive innovation, in the biotechnology sector, specifically in Absci Corp, which operates in the AI-powered drug discovery space.

Stakeholder Impact

• Shareholders may view the continued significant stake by ARK Investment Management and Catherine D. Wood as a positive indicator of institutional confidence in Absci Corp's long-term prospects.

Key Dates

Keywords

Absci Corp, ARK Investment Management, Catherine D. Wood, Schedule 13G, beneficial ownership, common stock, investment adviser, biotechnology, genomic revolution ETF